Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily

Genomics

Volumn 62, Issue 1, 1999, Pages 103-107

  Hu, Shimin ^a   Tamada, Koji ^a   Ni, Jian ^b   Vincenz, Claudius ^c   Chen, Lieping ^a  

^a MAYO CLINIC   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL SURFACE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSED SEQUENCE TAG; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE SPECIFICITY;

ANIMALIA; MURINAE;

EID: 0032734626     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5979     Document Type: Article

References (25)

1. Anderson D. M., Maraskovsky E., Billingsley W. L., Dougall W. C., Tometsko M. E., Roux E. R., Teepe M. C., DuBose R. F., Cosman D., Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175-179.
2. Arch R. H., Gedrich R. W., Thompson C. B. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death. Genes Dev. 12:1998;2821-2830.
3. Ashkenazi A., Dixit V. M. Death receptors: Signaling and modulation. Science. 281:1998;1305-1308.
4. Baker S. J., Reddy E. P. Modulation of life and death by the TNF receptor superfamily. Oncogene. 17:1998;3261-3270.
5. Banner D. W., D'Arcy A., Janes W., Gentz R., Schoenfeld H. J., Broger C., Loetscher H., Lesslauer W. Crystal structure of the soluble human 55 Kd TNF receptor-human TNF complex: Implications for TNF receptor activation. Cell. 73:1993;431-445.
6. Bodmer J. L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schroter M., Becker K., Wilson A., French L. E., Browning J. L., MacDonald H. R., Tschopp J. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity. 6:1997;79-88.
7. Chicheportiche Y., Bourdon P. R., Xu H., Hsu Y. M., Scott H., Hession C., Garcia I., Browning J. L. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272:1997;32401-34210.
8. Chinnaiyan A. M., O'Rourke K., Yu G. L., Lyons R. H., Garg M., Duan D. R., Xing L., Gentz R., Ni J., Dixit V. M. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 274:1996;990-992.
9. Dragovich T., Rudin C. M., Thompson C. B. Signal transduction pathways that regulate cell survival and cell death. Oncogene. 17:1998;3207-3213.
10. Gravestein L. A., Borst J. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10:1998;423-434.
11. Hahne M., Kataoka T., Schroter M., Hofmann K., Irmler M., Bodmer J. L., Schneider P., Bornand T., Holler N., French L. E., Sordat B., Rimoldi D., Tschopp J. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188:1998;1185-1190.
12. Hu S., Vincenz C., Ni J., Gentz R., Dixit V. M. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J. Biol. Chem. 272:1997;17255-17257.
13. Kitson J., Raven T., Jiang Y. P., Goeddel D. V., Giles K. M., Pun K. T., Grinham C. J., Brown R., Farrow S. N. A death-domain-containing receptor that mediates apoptosis. Nature. 384:1996;372-375.
14. Lacey D. L., Timms E., Tan H. L., Kelley M. J., Dunstan C. R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y. X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
15. Marsters S. A., Sheridan J. P., Pitti R. M., Brush J., Goddard A., Ashkenazi A. Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 8:1998;525-528.
16. Mauri D. N., Ebner R., Montgomery R. I., Kochel K. D., Cheung T. C., Yu G. L., Ruben S., Murphy M., Eisenberg R. J., Cohen G. H., Spear P. G., Ware C. F. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:1998;21-30.
17. Melero I., Bach N., Hellstrom K. E., Aruffo A., Mittler R. S., Chen L. P. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway. Eur. J. Immunol. 28:1998;1116-1121.
18. Mukhopadhyay A., Ni J., Zhai Y., Yu G. L., Aggarwal B. B. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274:1999;15978-15981.
19. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J. L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R. H., Browning J. L., Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189:1999;1747-1756.
20. Screaton G. R., Xu X. N., Olsen A. L., Cowper A. E., Tan R., McMichael A. J., Bell J. I. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA. 94:1997;4615-4619.
21. Simonet W. S., Lacey D. L., Dunstan C. R., Kelley M., Chang M. S., Luthy R., Nguyen H. Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H. L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T. M., Hill D., Pattison W., Campbell P., Boyle W. J. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 89:1997;309-319.
22. Wong B. R., Rho J., Arron J., Robinson E., Orlinick J., Chao M., Kalachikov S., Cayani E., Bartlett F. S. III, Frankel W. N., Lee S. Y., Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:1997;25190-25194.
23. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA. 95:1998;3597-3602.
24. Yue T. L., Ni J., Romanic A. M., Gu J. L., Keller P., Wang C., Kumar S., Yu G. L., Hart T. K., Wang X., Xia Z., DeWolf W. E. Jr., Feuerstein G. Z. TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells - Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J. Biol. Chem. 274:1999;1479-1486.
25. Zhai Y., Ni J., Jiang G. W., Lu J., Xing L., Lincoln C., Carter K. C., Janat F., Kozak D., Xu S., Rojas L., Aggarwal B. B., Ruben S., Li L. Y., Gentz R., Yu G. L. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 13:1999;181-189.